Metastatic meningioma: a case series and systematic review.
(Epi)genomics
Meningioma
Metastatic
Oncology
Palliative
Recurrent
Screening
Journal
Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
received:
09
05
2023
accepted:
15
06
2023
medline:
5
10
2023
pubmed:
26
7
2023
entrez:
26
7
2023
Statut:
ppublish
Résumé
Meningiomas are the most common primary intracranial tumor. While the majority of meningiomas are benign, rarely they can metastasize extracranially. There is a need for a more comprehensive review of these patients to improve our understanding of this rare phenomenon and its prevalence globally. Here we describe our institution's experience of patients presenting with metastatic meningiomas. We further perform a systematic review of the existing literature to explore common features of this rare manifestation of meningioma and review the efficacy of current treatments. We performed a retrospective clinical review of all adult patients with metastatic meningioma managed at our institution over the past 20 years, identifying 6 patients. We then performed a systematic review of cases of metastatic meningioma in the literature ranging from the years 1886 to 2022. A descriptive analysis was then conducted on the available data from 1979 onward, focusing on the grade and location of the primary tumor as well as the latency period to, and location of, the metastasis. In total, we analyzed 155 cases. Fifty-four percent of patients initially presented with a primary meningioma located in the convexity. The most common site of metastasis was the lung. Risk factors associated with a shorter time to metastasis were male sex and a high initial grade of the tumor. Regarding treatment, the addition of chemotherapy was the most common adjunct to the standard management of surgery and radiotherapy. Despite an exhaustive review we were unable to identify effective treatments. The majority of published cases came from centers situated in high-income countries (84%) while only 16% came from lower- and middle-income countries. Metastatic meningiomas pose a pertinent, and likely underestimated, clinical challenge within modern neurosurgery. To optimize management, timely identification of these patients is important. More research is needed to explore the mechanisms underlying these tumors to better guide the development of effective screening and management protocols. However, screening of each meningioma patient is not feasible, and at the heart of this challenge is the inability to control the primary disease. Ultimately, a consensus is needed as to how to correctly screen for and manage these patients; genomic and epigenomic approaches could hold the answer to finding druggable targets.
Sections du résumé
BACKGROUND
Meningiomas are the most common primary intracranial tumor. While the majority of meningiomas are benign, rarely they can metastasize extracranially. There is a need for a more comprehensive review of these patients to improve our understanding of this rare phenomenon and its prevalence globally. Here we describe our institution's experience of patients presenting with metastatic meningiomas. We further perform a systematic review of the existing literature to explore common features of this rare manifestation of meningioma and review the efficacy of current treatments.
METHODS
We performed a retrospective clinical review of all adult patients with metastatic meningioma managed at our institution over the past 20 years, identifying 6 patients. We then performed a systematic review of cases of metastatic meningioma in the literature ranging from the years 1886 to 2022. A descriptive analysis was then conducted on the available data from 1979 onward, focusing on the grade and location of the primary tumor as well as the latency period to, and location of, the metastasis.
RESULTS
In total, we analyzed 155 cases. Fifty-four percent of patients initially presented with a primary meningioma located in the convexity. The most common site of metastasis was the lung. Risk factors associated with a shorter time to metastasis were male sex and a high initial grade of the tumor. Regarding treatment, the addition of chemotherapy was the most common adjunct to the standard management of surgery and radiotherapy. Despite an exhaustive review we were unable to identify effective treatments. The majority of published cases came from centers situated in high-income countries (84%) while only 16% came from lower- and middle-income countries.
CONCLUSIONS
Metastatic meningiomas pose a pertinent, and likely underestimated, clinical challenge within modern neurosurgery. To optimize management, timely identification of these patients is important. More research is needed to explore the mechanisms underlying these tumors to better guide the development of effective screening and management protocols. However, screening of each meningioma patient is not feasible, and at the heart of this challenge is the inability to control the primary disease. Ultimately, a consensus is needed as to how to correctly screen for and manage these patients; genomic and epigenomic approaches could hold the answer to finding druggable targets.
Identifiants
pubmed: 37491650
doi: 10.1007/s00701-023-05687-3
pii: 10.1007/s00701-023-05687-3
pmc: PMC10542723
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2873-2883Informations de copyright
© 2023. The Author(s).
Références
Alexandru D, Glantz MJ, Kim L, Chamberlain MC, Bota DA (2011) Pulmonary metastases in patients with recurrent, treatment-resistant meningioma: prognosis and identification by
doi: 10.1002/cncr.26065
pubmed: 21446045
Bayley JC, Hadley CC, Harmanci AO, Harmanci AS, Klisch TJ, Patel AJ (2022) Multiple approaches converge on three biological subtypes of meningioma and extract new insights from published studies. Sci Adv 8(5):eabm6247. https://doi.org/10.1126/sciadv.abm6247
doi: 10.1126/sciadv.abm6247
pubmed: 35108039
Bi WL, Greenwald NF, Abedalthagafi M et al (2017) Genomic landscape of high-grade meningiomas. Npj Genomic Med 2(1):1–14. https://doi.org/10.1038/s41525-017-0014-7
doi: 10.1038/s41525-017-0014-7
Brodbelt AR, Barclay ME, Greenberg D, Williams M, Jenkinson MD, Karabatsou K (2019) The outcome of patients with surgically treated meningioma in England: 1999–2013. A cancer registry data analysis. Br J Neurosurg. 33(6):641–647. https://doi.org/10.1080/02688697.2019.1661965
doi: 10.1080/02688697.2019.1661965
pubmed: 31526136
Chew SJY, Rajesvaran C, Woo X, Goh CH (2021) Atypical meningioma with nodal metastasis: a case report. Malays J Pathol 43(3):453–456
pubmed: 34958067
Choudhury A, Magill ST, Eaton CD et al (2022) Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat Genet 54(5):649–659. https://doi.org/10.1038/s41588-022-01061-8
doi: 10.1038/s41588-022-01061-8
pubmed: 35534562
pmcid: 9374001
Clark VE, Erson-Omay EZ, Serin A et al (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339(6123):1077–1080. https://doi.org/10.1126/science.1233009
doi: 10.1126/science.1233009
pubmed: 23348505
pmcid: 4808587
Cornelius JF, Slotty PJ, Steiger HJ, Hänggi D, Polivka M, George B (2013) Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases. Acta Neurochir (Wien) 155(3):407–413. https://doi.org/10.1007/s00701-012-1611-y
doi: 10.1007/s00701-012-1611-y
pubmed: 23318687
Corniola MV, Landis BN, Migliorini D et al (2017) Rapidly growing pulmonary metastasis from anaplastic meningioma with lethal outcome: a case report. J Neurol Surg Rep 78(4):e129–e134. https://doi.org/10.1055/s-0037-1615808
doi: 10.1055/s-0037-1615808
pubmed: 29302407
pmcid: 5746346
Dalle Ore CL, Magill ST, Yen AJ et al (2019) Meningioma metastases: incidence and proposed screening paradigm. J Neurosurg 132(5):1447–1455. https://doi.org/10.3171/2019.1.JNS181771
doi: 10.3171/2019.1.JNS181771
pubmed: 30952122
Delgado-López PD, Martín-Velasco V, Castilla-Díez JM et al (2006) Metastatic meningioma to the eleventh dorsal vertebral body: total en bloc spondylectomy. Case report and review of the literature. Neurocir Astur Spain 17(3):240–249. https://doi.org/10.1016/s1130-1473(06)70346-3
doi: 10.1016/s1130-1473(06)70346-3
Dincer A, Chow W, Shah R, Graham RS (2020) Infiltration of benign meningioma into sagittal sinus and subsequent metastasis to lung: case report and literature review. World Neurosurg 136:263–269. https://doi.org/10.1016/j.wneu.2019.12.131
doi: 10.1016/j.wneu.2019.12.131
pubmed: 31899401
Fountain DM, Young AMH, Santarius T (2020) Malignant meningiomas. Handb Clin Neurol 170:245–250. https://doi.org/10.1016/B978-0-12-822198-3.00044-6
doi: 10.1016/B978-0-12-822198-3.00044-6
pubmed: 32586496
Fountain DM, Smith MJ, O’Leary C et al (2021) The spatial phenotype of genotypically distinct meningiomas demonstrate potential implications of the embryology of the meninges. Oncogene 40(5):875–884. https://doi.org/10.1038/s41388-020-01568-6
doi: 10.1038/s41388-020-01568-6
pubmed: 33262459
Glasauer FE, Yuan RH (1963) Intracranial tumors with extracranial metastases. Case report and review of the literature. J Neurosurg. 20:474–493. https://doi.org/10.3171/jns.1963.20.6.0474
doi: 10.3171/jns.1963.20.6.0474
pubmed: 14193871
Goldbrunner R, Stavrinou P, Jenkinson MD et al (2021) EANO guideline on the diagnosis and management of meningiomas. Neuro-Oncol 23(11):1821–1834. https://doi.org/10.1093/neuonc/noab150
doi: 10.1093/neuonc/noab150
pubmed: 34181733
pmcid: 8563316
Golemi A, Ambrosini A, Cecchi P et al (2015) (68)Ga-DOTANOC PET/CT detection of multiple extracranial localizations in a patient with anaplastic meningioma. Rev Espanola Med Nucl E Imagen Mol 34(4):258–260. https://doi.org/10.1016/j.remn.2015.03.003
doi: 10.1016/j.remn.2015.03.003
Hanft S, Canoll P, Bruce JN (2010) A review of malignant meningiomas: diagnosis, characteristics, and treatment. J Neurooncol 99(3):433–443. https://doi.org/10.1007/s11060-010-0348-9
doi: 10.1007/s11060-010-0348-9
pubmed: 20730473
He N, Zhong L, Lei K (2020) Multiple pulmonary and pleural metastases in recurrent intracranial meningioma with genetic changes: case report and review of the literature. World Neurosurg 136:337–340. https://doi.org/10.1016/j.wneu.2020.01.060
doi: 10.1016/j.wneu.2020.01.060
pubmed: 31954911
Huntoon K, Yilmaz AS, Pietrzak M et al (2022) Genetic analysis of a malignant meningioma and associated metastases. Acta Neurochir (Wien) 164(5):1401–1405. https://doi.org/10.1007/s00701-021-05101-w
doi: 10.1007/s00701-021-05101-w
pubmed: 34981192
Kalamarides M, Stemmer-Rachamimov AO, Niwa-Kawakita M et al (2011) Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes. Oncogene 30(20):2333–2344. https://doi.org/10.1038/onc.2010.609
doi: 10.1038/onc.2010.609
pubmed: 21242963
Kane AJ, Sughrue ME, Rutkowski MJ et al (2011) Anatomic location is a risk factor for atypical and malignant meningiomas. Cancer 117(6):1272–1278. https://doi.org/10.1002/cncr.25591
doi: 10.1002/cncr.25591
pubmed: 21381014
Kanzaki R, Higashiyama M, Fujiwara A et al (2011) Surgical resection of pulmonary metastases from meningioma: report of a case. Surg Today 41(7):995–998. https://doi.org/10.1007/s00595-010-4409-7
doi: 10.1007/s00595-010-4409-7
pubmed: 21748620
Kerr K, Qualmann K, Esquenazi Y, Hagan J, Kim DH (2018) Familial syndromes involving meningiomas provide mechanistic insight into sporadic disease. Neurosurgery 83(6):1107–1118. https://doi.org/10.1093/neuros/nyy121
doi: 10.1093/neuros/nyy121
pubmed: 29660026
pmcid: 6235681
Lanfranchi M, Nikpoor N (2013) Detection of meningioma metastasis to liver and lung using somatostatin receptor scintigraphy. Clin Nucl Med 38(8):668–670. https://doi.org/10.1097/RLU.0b013e31829962ac
doi: 10.1097/RLU.0b013e31829962ac
pubmed: 23797223
Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-Oncol 23(8):1231–1251. https://doi.org/10.1093/neuonc/noab106
doi: 10.1093/neuonc/noab106
pubmed: 34185076
pmcid: 8328013
Ma J, Hong Y, Chen W et al (2020) High copy-number variation burdens in cranial meningiomas from patients with diverse clinical phenotypes characterized by hot genomic structure changes. Front Oncol 10. Accessed May 30, 2022. https://www.frontiersin.org/article/10.3389/fonc.2020.01382
Maas SLN, Stichel D, Hielscher T et al (2021) Integrated molecular-morphologic meningioma classification: a multicenter retrospective analysis, retrospectively and prospectively validated. J Clin Oncol 39(34):3839–3852. https://doi.org/10.1200/JCO.21.00784
doi: 10.1200/JCO.21.00784
pubmed: 34618539
pmcid: 8713596
Magill ST, Young JS, Chae R, Aghi MK, Theodosopoulos PV, McDermott MW (2018) Relationship between tumor location, size, and WHO grade in meningioma. Neurosurg Focus 44(4):E4. https://doi.org/10.3171/2018.1.FOCUS17752
doi: 10.3171/2018.1.FOCUS17752
pubmed: 29606048
McCarthy C, Hofer M, Vlychou M et al (2016) Metastatic meningioma presenting as a malignant soft tissue tumour. Clin Sarcoma Res 6:23. https://doi.org/10.1186/s13569-016-0063-1
doi: 10.1186/s13569-016-0063-1
pubmed: 28042470
pmcid: 5200959
Moubayed SP, Guertin L, Lambert C, Desrochers P, Nehmé J, Coulombe G (2013) Successful treatment of anaplastic meningioma metastatic to cervical lymph nodes. Head Neck 35(4):E115-118. https://doi.org/10.1002/hed.21938
doi: 10.1002/hed.21938
pubmed: 22083757
Nassiri F, Liu J, Patil V et al (2021) A clinically applicable integrative molecular classification of meningiomas. Nature 597(7874):119–125. https://doi.org/10.1038/s41586-021-03850-3
doi: 10.1038/s41586-021-03850-3
pubmed: 34433969
Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 372:n71. https://doi.org/10.1136/bmj.n71
doi: 10.1136/bmj.n71
pubmed: 33782057
pmcid: 8005924
Patel AP, Fisher JL, Nichols E et al (2019) Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(4):376–393. https://doi.org/10.1016/S1474-4422(18)30468-X
doi: 10.1016/S1474-4422(18)30468-X
Perry A (2021) The definition and role of brain invasion in meningioma grading: Still controversial after all these years. Free Neuropathol 2:8–8. https://doi.org/10.17879/freeneuropathology-2021-3276
doi: 10.17879/freeneuropathology-2021-3276
Power D (1886) Fibrosarcoma of the dura mater. Trans Pathol Soc Lond 37:12–14
Rogers L, Barani I, Chamberlain M et al (2015) Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 122(1):4–23. https://doi.org/10.3171/2014.7.JNS131644
doi: 10.3171/2014.7.JNS131644
pubmed: 25343186
pmcid: 5062955
Sahm F, Schrimpf D, Stichel D et al (2017) DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 18(5):682–694. https://doi.org/10.1016/S1470-2045(17)30155-9
doi: 10.1016/S1470-2045(17)30155-9
pubmed: 28314689
Sun C, Dou Z, Wu J et al. (2020) The preferred locations of meningioma according to different biological characteristics based on voxel-wise analysis. Front Oncol 10. Accessed May 30, 2022. https://www.frontiersin.org/article/10.3389/fonc.2020.01412
Surov A, Gottschling S, Bolz J et al (2013) Distant metastases in meningioma: an underestimated problem. J Neurooncol 112(3):323–327. https://doi.org/10.1007/s11060-013-1074-x
doi: 10.1007/s11060-013-1074-x
pubmed: 23404622
Vuong HG, Ngo TNM, Dunn IF (2021) Incidence, risk factors, and prognosis of meningiomas with distant metastases at presentation. Neuro-Oncol Adv. 3(1):vdab084. https://doi.org/10.1093/noajnl/vdab084
doi: 10.1093/noajnl/vdab084
Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99(3):307–314. https://doi.org/10.1007/s11060-010-0386-3
doi: 10.1007/s11060-010-0386-3
pubmed: 20821343
pmcid: 2945461
World Bank Country and Lending Groups – World Bank Data Help Desk. Accessed April 10, 2022. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
Youngblood MW, Miyagishima DF, Jin L et al (2021) Associations of meningioma molecular subgroup and tumor recurrence. Neuro-Oncol 23(5):783–794. https://doi.org/10.1093/neuonc/noaa226
doi: 10.1093/neuonc/noaa226
pubmed: 33068421
Youngblood MW, Duran D, Montejo JD et al (2019) Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas. J Neurosurg. Published online .1–10. https://doi.org/10.3171/2019.8.JNS191266